Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Synthetic Genistein in Localized Prostate Cancer
NCT00546039Phase 2Unknown
- Sponsor
- Aker Hospital
- Start
- Apr 2007
- Primary completion
- Aug 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in prostate cancer (PCa) comparing Genistein with Placebo (2 arms). Primary endpoint: Modulation of biomarkers in blood and/or prostate tissue. Status: unknown.
02
Drugs
genistein
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00546039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00546039.